Skip to main content
Clinical Trials/NCT03919513
NCT03919513
Completed
Not Applicable

Effect of Combined Inspiratory Muscle Training and Continuous Positive Airway Pressure in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease.

Zhujiang Hospital1 site in 1 country30 target enrollmentMay 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary Rehabilitation
Sponsor
Zhujiang Hospital
Enrollment
30
Locations
1
Primary Endpoint
Respiratory muscle strength(composite outcome measure)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Inspiratory muscle training(IMT) was one of the widely used pulmonary rehabilitation method in COPD patients.However, when the respiratory muscles are fatigue without sufficient rest, IMT may increase muscle fatigue and aggravate muscle damage. Noninvasive positive pressure ventilation (NPPV) is another important strategy of pulmonary rehabilitation which could overcome airway resistance and reduce respiratory work, improve respiratory muscle fatigue. Therefore, the purpose of this study was to explore the effective of the "IMT - NPPV sequential" rehabilitation method, that is, first inspiratory muscle training, followed by respiratory muscle resting (non-invasive positive pressure ventilation).

Detailed Description

Exploring the effects of the new rehabilitation method of "IMT - NPPV sequential", comparing with the single rehabilitation strategy such as inspiratory muscle training and non-invasive positive pressure ventilation.

Registry
clinicaltrials.gov
Start Date
May 1, 2019
End Date
May 1, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Zhujiang Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with pulmonary function test of forced expiratory volume at one second (FEV1)/forced vital capacity(FVC) \< 70% after inhalation of bronchial dilation agent. Patients in a clinically stable state.

Exclusion Criteria

  • Patients were excluded if they had other respiratory diseases ,or evidence of pneumothorax or mediastinal emphysema and pacemaker installed.
  • Patients with acute cardiovascular event and severe cor pulmonale. Patients with poor compliance. An Other causes of diaphragmatic dysfunction

Outcomes

Primary Outcomes

Respiratory muscle strength(composite outcome measure)

Time Frame: Change from baseline to 8 weeks

Currently, the maximal inspiratory pressure (PImax) and maximal expiratory pressures(PEmax) are measured by a digital manometer (AZ-8205, AZ Instrument, Taichung City, Taiwan)and combined to evaluate respiratory muscle function.

Secondary Outcomes

  • Exercise capacity(Change from baseline to 8 weeks)
  • Pulmonary function(composite outcome measure)(Change from baseline to 8 weeks)
  • Symptom Evaluation(composite outcome measure)(Change from baseline to 8 weeks)
  • Diaphragmatic function(Change from baseline to 8 weeks)

Study Sites (1)

Loading locations...

Similar Trials